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Abstract
The connective tissue formed by extracellular matrix (ECM) rich in fibronectin and collagen
consists a barrier that cancer cells have to overpass to reach blood vessels and then a meta-
static site. Cell adhesion to fibronectin is mediated by αvβ3 and α5β1 integrins through an
RGD motif present in this ECM protein, thus making these receptors key targets for cell
migration studies. Here we investigated the effect of an RGD disintegrin, DisBa-01, on the
migration of human fibroblasts (BJ) and oral squamous cancer cells (OSCC, SCC25) on a
fibronectin-rich environment. Time-lapse images were acquired on fibronectin-coated glass-
bottomed dishes. Migration speed and directionality analysis indicated that OSCC cells, but
not fibroblasts, showed significant decrease in both parameters in the presence of DisBa-01
(1μM and 2μM). Integrin expression levels of the α5, αv and β3 subunits were similar in both
cell lines, while β1 subunit is present in lower levels on the cancer cells. Next, we examined
whether the effects of DisBa-01 were related to changes in adhesion properties by using
paxillin immunostaining and total internal reflection fluorescence TIRF microscopy. OSCCs
in the presence of DisBa-01 showed increased adhesion sizes and number of maturing
adhesion. The same parameters were analyzed usingβ3-GFP overexpressing cells and
showed that β3 overexpression restored cell migration velocity and the number of maturing
adhesion that were altered by DisBa-01. Surface plasmon resonance analysis showed that
DisBa-01 has 100x higher affinity for αvβ3 integrin than forα5β1 integrin. In conclusion, our
results suggest that the αvβ3 integrin is the main receptor involved in cell directionality and
its blockage may be an interesting alternative against metastasis.
Introduction
Oral squamous cell carcinoma (OSCC) is responsible for 90% of all oral cancers occurring at
different sites of the oral mucosa [1, 2]. The exposure to chemical, physical or biological agents
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with mutagenic and carcinogenic properties leads mutated keratinocytes to proliferate and
invade the connective tissue. OSCCs responsiveness to chemotherapy is low likely due to the
heterogeneity of tumor cell population; the high local recurrence rate of this disease results in
a 5 year survival rate of only 40–50% [2, 3].
Tumor cell migration is pivotal step in invasion and metastases. The change from a non-
migratory to a migratory phenotype results in detachment from the primary tumor, invasion
into the surrounding tissues, and entry into blood and lymph vessels [4, 5]. Throughout this
process, epithelial-derived tumor cells need to adapt to the changing environment, reflecting
the change from a laminin-enriched basal membrane to a connective tissue rich in fibronectin
and collagen. Previous studies showed that more aggressive OSCCs correlate with increased
presence of fibronectin throughout the tissue, particularly at the invasion front [6, 7], which
might result in a fast single-cell migration mode [8].
Cell migration is a complex and cyclic process mediated by adhesion molecules such as the
integrin receptors [9–11]. They are composed of two different subunits, α and β which may
assemble into 24 differently combined heterodimers with individual specificities to ECM pro-
teins. Although some integrins share affinity to the same ligands, they may trigger different sig-
naling pathways [12–14] such as the integrins α5β1 and αvβ3 that bind to fibronectin through a
RGD (arginine-glycine-aspartic acid) motif but differentially regulates adhesion maturation
[15, 16]. Therefore, the use of peptides that bind to integrins could be considered a strategy to
impair cell motility and decrease the possibility of metastasis.
Therefore, the blockage of integrin activity affects several adhesion dependent processes as
migration, proliferation, apoptosis, among other processes [17–21]. For instance, disintegrins,
a family of low molecular weight, cysteine-rich peptides discovered in snake venoms were
found to cause platelet aggregation inhibition, by binding to the integrin αIIbβ3 [22, 23].
DisBa-01 (disintegrin of Bothrops alternatus) is a recombinant RGD containing disintegrin
that inhibits cell migration [24], in vivo angiogenesis [25], pulmonary metastasis [26] and is
able to decrease the expression of VEGF receptors in endothelial cells [27]. Since ECM compo-
nents are able to modify the adhesion properties of tumor cells and elicit a migratory behavior
[28], we hypothesized that the selective blockage of integrin receptors by an RGD disintegrin
might impair the migratory process of OSCC cells on a fibronectin enriched environment.
In this study, we show that DisBa-01 decreased migration speed, directionality and changed
the migration mode of a highly invasive OSCC cell line from single to collective cell migration
but had no effect on fibroblasts. This selective effect on epithelial-derived tumor cells was
accompanied by a modulation of adhesion dynamics and was rescued by the overexpression of
β3 integrin. Together, these data strongly suggest thatαvβ3 integrin is the major receptor
involved in cell speed and directionality of OSCCs and it can be a critical target for therapy
against metastasis.
Material and methods
DisBa-01 expression and purification
DisBa-01 is a recombinant disintegrin produced from a cDNA venom gland library of B. alter-
natus, since the native disintegrin could not be purified from the venom due to low yields in
protein preparations [26]. The coding region corresponds to an RGD containing motif disinte-
grin of 78 amino acids residues (GenBank accession AY259516). Expression and purification
of the recombinant His-tag protein were performed as previously described [26]. Molecular
modeling and adhesion assays suggested that the fusion His-tag peptide was not involved on
integrin binding and therefore its proteolytic removal would not be needed [26–27].
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Cell culture and transfection
SCC25 cells (ATCC1 CRL-1628™) were grown in DMEM/F12 with 15mM HEPES and 0.5mM
sodium pyruvate (Gibco), FBS 10% and hydrocortisone (400ng/ml, Sigma), while BJ cells
(ATCC1 CRL2522™) in DMEM Glutamax with 1% non-essential amino acids (NEAA) and
10% fetal bovine serum. Cal27 (ATCC1 CRL-2095™) were cultivated in DMEM high glucose
(Gibco) supplemented with 10% Fetal Bovine Serum (FBS). All cells were maintained in incu-
bator at 37˚C and 5% CO2. SCC25 cell was considered a highly aggressive oral squamous cell
carcinoma (OSCC) cell line due to its low E-cadherin content when compared to Cal27, an
OSCC cell line considered to be minimally invasive [28]. For Total Internal Reflectance Fluo-
rescence (TIRF) microscopy, SCC25 were transfected using TransIT-2020 (Mirus) 24hs before
the experiment with 0.5μg of paxillin-GFP plasmid [29]. For β3 subunit overexpression stud-
ies, cells were transfected with 0.5μg β3-GFP and 0.5μg paxillin-mko.
Migration and adhesions dynamics assays. Both assays used 3cm glass-bottomed dishes
containing fibronectin (2μg/mL) and/or DisBa-01 (1 and 2μM) as a substrate or diluted in the
media. Cells were plated with serum free media (CCM1, Thermo Fisher Scientific) and left in
the incubator at 37˚C for 1 hour (phase microscopy) or 20 min (TIRF microscopy) before
imaging. At least 3 different experiments were performed for each group.
For time-lapse phase microscopy, images were acquired from either: BJ (human fibroblasts)
and SCC25 (OSCC) over 8 hours with a 10 minute interval, at 37˚C using a Nikon TE300
microscope (10x 0.25 NA CFI Achro DL106 Nikon objective), with a charge coupled device
camera (Orca II, Hamamatsu Photonics, Iwata-City, Japan) using Metamorph software
(Molecular Devices), as previously described [30]. Image J software in manual tracking was
used to analyze migration parameters. Migration speed was determined by the ratio between
the total distance and duration of cell migration; while directionality was determined by X and
Y coordinates normalized to a “zero” starting point.
For time-lapse movies on TIRF microscopy, only the SCC25 cell was used. Images were
captured every 3 seconds over 20 minutes using an Olympus IX70 inverted microscope (63x
1.45 NA oil Olympus PlanAplo 660 TIRFM objective), fitted with a Ludl modular automation
controller (Ludl Electronic Products), a charge-couple device camera (RetigaExi, Qimaging),
and Metamorph software. GFP was excited using the 488nm laser line of an Argon laser
(Melles Griot), a dichroic mirror (HQ485/30) and an emission filter (HQ525/50). To estimate
the rate of adhesion maturation, nascent adhesions were identified as the adhesions formed at
the border of the cell membrane during protrusion and mature adhesions were identified as
those that persisted through membrane protrusion, growing in size and elongating.
Additionally, invasion assays were made using 24-well plate Matrigel™ invasion chambers
(Corning). DMEM/F12 medium with 5% FBS was pipetted into the wells, except on the nega-
tive control where serum-free F12 medium was used. SCC-25 cells (1 x 105 cells) were treated
with 1000 nM or 2000 nM DisBa-01 on serum-free F12 medium for 30 minutes. After that, the
membrane-containing chamber was added to the well and treated or not-treated cells were
applied. The invasion occurred for 48 hours at 37˚C. The chamber membrane was fixed in 4%
paraformaldehyde and cell nucleus was stained using DAPI. Membranes were assembled in
slides using Vectashield1 mounting media (Vector Laboratories) and cell count was per-
formed on automated fluorescence microscope system, ImageXpress Micro (Molecular
Devices).
Western blots. Cells were trypsinized, washed and lysed in RIPA Buffer (25mMTris-HCL
pH 7.6, 150mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) with protease (P8340,
Sigma Aldrich) and phosphate cocktails (P8340, Sigma Aldrich). The lysates were separated by
4–20% precast polyacrylamide gel (BioRad) and proteins transferred to PVDF membranes
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(BioRad), blocked for 1 hour with 5% defatted milk in a PBS/0.5% Tween 20 at room tempera-
ture. Samples were immunoassayed for αv, β3, α5, β1, E-cadherin, N-cadherin and α-Tubulin
(Cell Signaling, USA) using Pierce ECL Western Blotting Substrate (Thermo Scientific).
Immunofluorescence. Cells were incubated with DisBa-01 for 3 hours on fibronectin
(2μg/ml) covered glass coverslips on CCM1 media. Then, cells were washed with PBS, fixed
with formaldehyde 4%, and permeabilized using TritonX-100 (0.3%). Nonspecific binding
sites were blocked with normal goat serum, and the cells incubated overnight with anti-paxilin
antibody (BD Bioscience). After washing, cells were incubated with secondary antibodies
against mouse bound to Alexa488 dye (Molecular Probes, Oregon, USA) and the actin fila-
ments were marked with phalloidin conjugated to rhodamine (Molecular Probes, Oregon,
USA). Images were obtained on a confocal microscope (Olympus FluoView 1000, Tokyo,
Japan) with the 63x objective (UPlanSApo x63, 1.20 NA, oil immersion objective). Alexa488
was excited via the 488nm line of an Ar laser (Melles Griot, Albuquerque, NM), and rhoda-
mine via the 543nm line of a Helium-Neon laser (Melles Griot, Albuquerque, NM). Images
were acquired using FluoView software (Olympus, Tokyo, Japan). The Z-stacks were acquired
from cells using 3 0.1μm step size slices (0.3μm of the cell) that were merged using the ImageJ
software tool “Z-stack/sum”.
Surface plasmon resonance (SPR). The affinity of DisBa-01 to immobilized integrins was
measured using SPR (BIAcore T200; GE Healthcare, Little Chalfont, UK). α5β1 and αVβ3 integ-
rins (R&D, Minneapolis, MN, USA) were covalently attached via amine coupling (pH Scout-
ing) to sensor chip CM5(GE Healthcare, Little Chalfont, UK). The bound ligand was then
perfused in buffer containing 0.01 M Hepes, pH 7.4, 0.15 M NaCl, and 0.005 (v/v) Surfactant
P20 (HBS–EP) at 25˚C and flow rate of 30 μL/min. Association and dissociation constant rates
were calculated by curve fitting, using BIA evaluation 1.1 software, assuming that DisBa-01 is
monomeric with a MR of 12,000 Da. After testing the sensor chip in a pH gradient (pH Scout-
ing), integrins α5β1 (pH 4.5) and αVβ3 (pH 4.0) were immobilized onto the sensor chip to get a
4,325.2 RU (Resonance Unit) and a 6,677.1 RU, respectively. Chip regeneration was done by
injection of Gly HCl 2M, pH 2.0 for 10s. DisBa-01 (0.1–100 μM) was injected at increasing
concentrations onto the sensor chip with both immobilized integrins and the association con-
stant between DisBa–01 and the integrins was calculated via GraFit 5.0 software.
Statistical analysis
One way analysis of variance (ANOVA) was used followed by Tukey´s post test and student t-
test for the TIRF microscopy assays.
Results
DisBa-01 selectively affects OSCC migration
As shown in our previous work, DisBa-01 inhibits cancer cell and fibroblast migration using a
transwell migration assay [24]. Therefore, to investigate its potential effect on cell migration in
a fibronectin rich environment we used two human cell lines that exhibit single cell migration:
fibroblasts (BJ) and a highly invasive/low differentiated oral squamous carcinoma cell line
(SCC25).Time-lapse movies (8h) were performed on both cell lines plated on glass-bottomed
dishes coated with fibronectin (2μg/ml) in the presence/absence of DisBa-01 (1 or 2μM) in the
media or in the substrate. Individual migratory cells were tracked and analyzed for migration
speed and directionality (total net translocation from the origin point). The fibroblasts (n = 3
experiments) were not detectably affected by DisBa-01, even at a high concentrations (2μM)
when compared with control cells (Fig 1A, S1 Movie). However, the OSCC migration speed
decreased by ~40% (n = 3 experiments, p<0.0001) when plated in the presence of similar
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amounts of DisBa-01. This effect was more pronounced for migration directionality (Fig 1B,
S2 Movie). While OSCC plated only in fibronectin exhibited a fast, individual and directionally
persistent migration behavior, cells treated with 1μM of DisBa-01 in the media or in the sub-
strate lost their directionality and moved in circles with a tendency to migrate in pairs (collec-
tively). This selective effect of DisBa-01 in the tumor cells migration may reflect a differential
effect on cell-ECM adhesive properties.
DisBa-01 modulates cells adhesive properties of OSCC
We studied whether DisBa-01effects arose from altered adhesion by immunostaining OSCCs
and fibroblasts for paxillin, a marker for nascent adhesions [31].Fibroblasts have small adhe-
sions at the cell border, which are present in rapidly migrating but not stationary cells. DisBa-
01 showed no alterations on paxillin distribution for these cells (Fig 2A). In contrast, signifi-
cant changes were observed in the adhesions in OSCCs, including an increase in the size and
number of adhesions in the presence of DisBa-01 in the media or in the substrate when com-
pared to cells plated only on fibronectin (Fig 2B).
To further investigate the adhesion dynamics seen at the paxillin immunostaining, SCC25
cells were transfected with paxillin-GFP and plated on fibronectin coated dishes (2μg/mL) 24h
later in the presence/absence of DisBa-01 in the media or in the substrate. Then, maturation
rate was imaged on TIRF microscopy every 3 seconds during 20 minutes. DisBa-01 increased
the rate of adhesion maturation and the average area of each adhesion in OSCCs (Fig 2, S3
Movie). During the migration process, cells extend their membrane to form the lamellipodia
and then attach the membrane to the extracellular matrix. The area of these protruding
Fig 1. DisBa-01 inhibits the migration of OSCC cell line. (A) DisBa-01 significantly inhibited the migration
speed of Oral Squamous Cell Carcinoma cells (SCC25) cells but not in fibroblasts (BJ) on both conditions
tested (Media = DisBa-01 in the media; Subs = DisBa-01 in the substrate). Results were calculated as % of
control. Statistical analysis was performed using ANOVA (one-way) followed by Tukey’s post-test, p<0.0001.
(B) Migration tracks of SCC25 cells treated with DisBa-01 in the concentrations of 2μM indicates a loss of
directionality when compared to the control tracks. Each individual line represents a cell path translated to a
common origin.
https://doi.org/10.1371/journal.pone.0176226.g001
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membranes was also measured and it was ~3x larger in DisBa-01 treated OSCC than control
cells (n = 3 cells, p>0.0005). Taken together, these data show that DisBa-01exhibits a differen-
tial cell type dependent effect on cell adhesion properties.
Fibronectin is a glycoprotein found on the ECM that interacts mainly with integrins αvβ3
and α5β1 through the RGD motifs in its structure [15, 32]. A possible mechanism for the differ-
ential effects of DisBa-01 on adhesion properties is that the cell lines show different levels of
integrin receptors for fibronectin. To test this hypothesis, we analyzed the integrin expression
level on fibroblasts (BJ), a highly invasive/low differentiated (SCC25) and a low invasive/highly
differentiated (Cal27) OSCC cell line (Fig 3). We observed that the low invasive/high differen-
tiated OSCC cell line (Cal27) presents only low levels of αv subunit, which might explain the
poor migratory performance observed on fibronectin [8]. However, fibroblasts showed high
levels of all fibronectin-related integrin subunits, which corroborates to the fast single cell
Fig 2. OSCCs treated with DisBa-01 show an increase in adhesions area and turnover. Cells were allowed to spread for 3 hours on fibronectin
(2μg/ml) coated dishes, subsequently fixed, stained for paxillin and analyzed by confocal microscopy. (A) Fibroblasts show a large number of small
adhesions (red arrow) with no differences between cells with or without DisBa-01 treatment, while SSC25 treated cells show larger (red arrow)
adhesions and rounded shape morphology in the presence of DisBa-01 (2μM). Actin staining and negative control are shown on the right. (B)
Percentage of maturing adhesions on TIRF time-lapse movies in the absence or presence of DisBa-01, (C) in the adhesion area (D) and in the
protrusions area (p<0.05). Data was obtained from 3 independent experiments resulting in the analysis of 13–15 protrusions and 64–84 adhesions
per experimental condition.
https://doi.org/10.1371/journal.pone.0176226.g002
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migration phenotype. When we analyzed the integrin levels of the highly invasive OSCC cell
line, besides the high level of alpha-subunits, these cells show low levels of β1 and high levels of
β3 subunits, which indicates that the migration process of this epithelial-derived tumor cell
line on fibronectin relies mostly on β3 activity. Since DisBa-01 is an RGD disintegrin, this
result suggests that DisBa-01 could be selectively acting on αvβ3 integrin of OSCC cells. Since
highly invasive OSCC cells migrate in a collective way in matrigel but individually in fibronec-
tin [8], we also tested if DisBa-01 could inhibit matrigel invasion. In fact, DisBa-01 (1 and
2 μM) inhibited OSCC invasion (approx. 40 and 50%, respectively) through matrigel (S1 Fig),
thus indicating that this disintegrin can inhibit both forms of migration.
To further analyze this result and confirm that the effects of DisBa-01 on migration and adhe-
sion of OSCC cells were caused by the interaction of the disintegrin with the αvβ3 and not
α5β1integrin, the main receptors involved in fibronectin binding [15], the binding between the
disintegrin and purified integrins (αvβ3, α5β1) were analyzed by SPR. The interaction between
DisBa-01 and the αvβ3 integrin was about 100x higher than that for α5β1integrin (Kd 7.62 x10–5M)
indicating a stronger affinity of the disintegrin for the αvβ3integrin. This difference can also be
seen in Fig 4.
β3 overexpression recovered DisBa-01 effects
DisBa-01 interacts with αvβ3 integrins [26], suggesting that the interaction between DisBa-01
and integrins impairs the migratory activity of OSCC cells. To test this hypothesis, OSCCs
were transfected with β3 subunit, plated on fibronectin-covered dishes in the presence/absence
of DisBa-01, and migration properties were assessed. Expression levels of two plasmid concen-
trations for β3 subunit had shown that the lower concentration had little effect whereas the
higher concentration, the chosen one, was closer to the BJ integrin levels (Fig 5A, S4 Movie). It
was observed that the overexpression of β3 subunit restored the migration speed and direction-
ality of cells plated in the presence of DisBa-01. Adhesion and protrusion areas of cells overex-
pressing β3 integrin with or without DisBa-01 were assessed both by immunostaining for
paxillin and co-transfection with paxillin-mkousing confocal and TIRF microscopy,
Fig 3. Fibronectin-related integrin receptors show differential expression according to the
differentiation level of the tumor cell. Cells lysates of fibroblasts (BJ), highly invasive OSCC (SCC25) or
poor invasive OSCC (Cal27 were submitted to western blot for analysis of fibronectin-related integrins. BJ and
SCC25 contain αv, β3 and α5 integrin subunits in similar amounts while β1 is present in smaller amounts on
SCC25 cells. E-cadherin and N-cadherin are differentiation markers.
https://doi.org/10.1371/journal.pone.0176226.g003
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respectively. Overexpression of β3 integrin rescued cells from a phenotype of larger adhesions
and protrusions and slower migration (Fig 5 and S5 Movie) such as the phenotype induced
byDisBa-01 (2μM), which corroborates with the hypothesis that the inhibition of β3 integrin
by DisBa-01is the probable mechanism by which DisBa-01 impairs the migration properties of
OSCC cells.
Fig 4. DisBa-01 interacts specifically with integrin αVβ3. (A) Response of increasing concentrations of
DisBa-01 interacting with the αVβ3 integrin immobilized to the sensor chip. Starting at the time “0” and
increasing its affinity as DisBa-01 concentration increases. (B) Response of increasing concentrations of
DisBa-01 interacting with the α5β1. As the concentration of DisBa-01 increases, the affinity curves show very
little displacement. (Single column- print in color)
https://doi.org/10.1371/journal.pone.0176226.g004
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Discussion
Tumor metastasis is a major cause of clinical failure in cancer treatment and might be influ-
enced by extrinsic factors, such as the composition of the environment, as well as by intrinsic
migratory properties of tumor cells. Also, tumor cell plasticity is a response to micro environ-
mental changes and often influences tumor progression, invasion and resistance to therapy
[33, 34]. Alterations in matrix density, pliability, and composition, the nature of the adhesion
receptors such as integrins or cadherins, respectively, and expression of cytoskeletal adaptor
proteins can lead to interconvertible changes on migration mode depending on each cell
intrinsic capacities [8, 34]. Therefore, the blockage of the interaction of tumor cells with the
extracellular matrix is an interesting alternative for complementary therapies. For instance,
cilengitide is a RGD cyclic pentapeptide that selectively inhibits of αvβ5 and αvβ3 integrins and
results from phase 2 trials show an antitumor activity against glioblastoma although it failed to
improve patient outcome in phase 3 trials [35–36]. Despite this fact, targeting integrins
Fig 5. Overexpression of β3 subunit recovered DisBa-01 effects on migration speed and adhesion
dynamics of OSCC cells. (A) SCC25 cells were transfected with GFP-β3 0.5 and 1μg of plasmid. Protein
bands show the levels of GFP-β3 and endogenous β3 expressed by SCC25 cells. (B) Migrations speed
analysis shows no differences between control and DisBa-01 treated cells. (C) Representative images of β3
overexpressing cells (indicated with arrows) stained for paxillin. (D) β3 overexpressing cells with DisBa-01
reduced the number of adhesions maturation, similar to the controls, when compared with the previous TIRF
experiment. (E) DisBa-01 effect over the area of adhesions and (F) area of protrusion was also was reverted on
β3 overexpressing cells treated with DisBa-01.
https://doi.org/10.1371/journal.pone.0176226.g005
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remains an interesting strategy to disrupt cell-matrix interactions in cancer therapy, according
to the authors.
We demonstrated that DisBa-01, an RGD disintegrin, present on media or substrate, was
able to significantly decrease cell migration and cell directionality of highly invasive OSCC, on
fibronectin coated dishes but it did not affect fibroblasts. Since soluble and immobilized disin-
tegrin forms triggered opposite results in the past [37], both forms were tested. Migration initi-
ates with biochemical or mechanical cues from the extracellular environment [11, 38]. As
demonstrated by previous studies, fibronectin induces migration of different cells lines includ-
ing low and highly differentiated OSCC cells [8, 39–40]. One interesting finding was that
OSCC cells in the presence of DisBa-01 migrated in a similar fashion of low invasive OSCC
cells, Cal27, also plated over fibronectin. Cells moved in circles and in a collective way, indicat-
ing loss of directionality and a change on the migration mode that leads toward a less aggressive
cell migration phenotype [8]. Another small RGD containing motif disintegrin, eristostatin, was
reported to decrease migration speed in a wound healing assay using fibronectin coated plates
and melanoma cells. Although it is not mentioned on the report, it is possible to notice impair-
ments on cells directionality and changes on cells morphology especially on the highly invasive
melanoma cell c8161 time-lapse videos [18]. According to Missirlis et al [39] the inhibition of
αvβ3 or α5β1 integrins, both on fibronectin coated surfaces caused cells to lose their directional-
ity, but with increased migration speed [39]. Cilengitide was also able to disrupt cell migration,
in time-lapse assays, decreasing by ~40%the migration speed in glioblastoma-derived cells,
although cells were not plated over fibronectin [41].
A possible mechanism of action for the impairment of cell migration by DisBa-01 is the
modulation of the adhesions. In order to better understand our results on the effects of DisBa-
01 on OSCC migration, we looked deeper into cell adhesion dynamics and morphology. Fast
migratory cells, such as leucocytes, are characterized by small and rapidly turning over adhe-
sions while slow adherent migratory cell possesses persistent adhesions that mature into larger
and elongated focal complexes [11, 40]. Highly invasive OSCC cells have small and dynamic
adhesions when plated on fibronectin, as it was already demonstrated [38]. Adhesion and pro-
trusion sizes were measured and when DisBa-01 was added to the cells, adhesions became
larger, with a higher rate of maturation and some instability could be noticed on membrane
protrusions. Blocking of α5β1but not αvβ3 integrin by a specific ligand also increased adhesion
sizes [39]. So adhesions function as anchors that respond to different stimuli and forces from
the ECM and/or cytoskeleton altering its shape, size and dynamics according to the environ-
ment during the migration process [42–44].
Variations in integrin expression could lead to different migratory phenotypes and how
cells are affected by DisBa-01. For instance, the blockage of β3 subunit by DisBa-01 did not
affect the migration performance of fibroblasts probably due to the high amounts of both β1
and β3 subunits present in this cell. However, our results on the migration speed inhibition of
OSCC could be due to DisBa-01 interaction with αvβ3 integrin that leaves cells with no proper
traction forces to migrate, although they are still adherent, since β1 subunit is present in very
limited amount. Moreover, β1 subunit has been characterized for promoting cell migration
with no directionality on fibronectin coated surfaces, [45] such as the motile behavior seen on
highly aggressive OSCC cell line in the presence of DisBa-01. This hypothesis was confirmed
by the higher affinity that DisBa-01 has for αvβ3 integrin, as Ramos et al [26] first demon-
strated and confirmed here, and its lower affinity for the integrin α5β1. Finally, the overexpres-
sion of β3 subunit on OSCC rescued the migratory phenotype once altered by DisBa-01
supporting the hypothesis that the major receptor of DisBa-01 is the integrin αvβ3. These data
show that, during invasion, epithelial-derived tumor cells switch the expression of integrins,
favoring those which interact with the connective tissue, and that the specific blockage of these
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receptors, might impair the invasive process. On the other hand, silencing of αvβ3 integrin was
recently demonstrated to decrease migration of both malignant glioma and triple negative
breast cancer cells [46, 47]. These studies are in complete agreement with our results.
To find new therapies for oral cancers, we showed that an RGD disintegrin changes the
migration behavior of an aggressive cancer cell by decreasing its migration speed, directional-
ity and changing adhesion phenotype upon αvβ3 integrin binding. This interesting phenome-
non highlights cell plasticity and turning it to our own benefit could be an achievable way to
fight against invasion and metastasis.
Supporting information
S1 Fig. Inhibition of cell invasion on matrigel in the presence of DisBa-01. The cells were
plated on the matrigel invasion inserts in the presence of DisBa-01 (1 μM and 2 μM) for 48 h.
Invasion was expressed as a percentage of the control (100%). Cells were counted with an auto-
mated fluorescence microscope system, ImageXpress Micro (Molecular Devices). ( p<0.05
compared to positive control).
(TIF)
S1 Movie. Fibroblasts migration in presence the absence/presence of DisBa-01 (2μM).
Time-lapse images captured during 8 hours at every 10 minutes (left column) and cell tracking
of migratory cells (right column). Fibroblasts were plated over fibronectin (upper line), fibro-
nectin + DisBa-01 (2μM) added to the media (center line) and fibronectin + DisBa-01 (2μM)
coated plates (bottom line).
(AVI)
S2 Movie. Highly invasive cells (OSCC) migration in presence the absence/presence of
DisBa-01 (2μM). Time-lapse images captured during 8 hours at every 10 minutes (left col-
umn) and cell tracking of migratory cells (right column). OSCC were plated over fibronectin
(upper line), fibronectin + DisBa-01 (2μM) added to the media (center line) and fibronectin
+ DisBa-01 (2μM) coated plates (bottom line).
(AVI)
S3 Movie. Adhesion dynamics of highly invasive OSCC cells. OSCC cells (SCC25) express-
ing the adhesion marker paxillin tagged with GFP were plated in fibronectin (left) or fibronec-
tin + DisBa-01 (2μM) in the media and imaged during 20 minutes at every 3 seconds using
Total Internal Reflectance Fluorescent (TIRF).
(AVI)
S4 Movie. β3 overexpressing highly invasive cells (OSCC) migration in presence the
absence/presence of DisBa-01 (2μM). Overexpressing β3OSCC subunit with images being
captured during 8 hours and every 10 minutes (left column) and cell tracking (right column).
Overexpressing β3OSCC migrating over fibronectin (upper line), overexpressing β3OSCC
migrating over fibronectin with DisBa-01 (2μM) added to the media (center line) and overex-
pressing β3OSCC migrating over fibronectin and DisBa-01 (2μM) coated plates (bottom line).
(AVI)
S5 Movie. Adhesion dynamics of highly invasive OSCC cells. OSCC cells (SCC25) express-
ing the adhesion marker paxillin tagged with mKO and β3 integrin were plated in fibronectin
(left) or fibronectin + DisBa-01 (2μM) in the media and imaged during 20 minutes at every 3
seconds using Total Internal Reflectance Fluorescent (TIRF).
(AVI)
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20. Olfa K-Z, José L, Salma D, Amine B, Najet SA, Nicolas A, et al. Lebestatin, a disintegrin from Macrovi-
pera venom, inhibits integrin-mediated cell adhesion, migration and angiogenesis. Lab Invest 2005; 85:
1507–16. https://doi.org/10.1038/labinvest.3700350 PMID: 16200076
21. Coelho AL, de Freitas MS, Oliveira-Carvalho AL, Moura-Neto V, Zingali RB, Barja-Fidalgo C. Effects of
jarastatin, a novel snake venom disintegrin, on neutrophil migration and actin cytoskeleton dynamics.
Exp Cell Res 1999; 251: 379–87. https://doi.org/10.1006/excr.1999.4583 PMID: 10471323
22. Huang TF. What have snakes taught us about integrins? Cell Mol Life Sci 1998; 54: 527–40. https://doi.
org/10.1007/s000180050181 PMID: 9676572
23. Gan Z, Gouldg RJ, Jacobs JW, Friedman PA, V MAP. Echis carinatus. J Biol Chemol Chem 1988; 263:
19827–32.
24. Selistre-de-Araujo HS, Pontes CLS, Montenegro CF, Martin ACBM. Snake venom disintegrins and cell
migration. Toxins (Basel) 2010; 2:2606–21.
25. Cassini-Vieira P, Deconte SR amos, Tomiosso TC arla, Campos PP eixoto, Montenegro C de F, Selis-
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